Skip to main content
Clinical Trials/NCT03706820
NCT03706820
Unknown
Not Applicable

Hemodynamic Study of the Pulmonary Circulation in Exercise in Patients With Pulmonary Fibrosis

Aristotle University Of Thessaloniki1 site in 1 country40 target enrollmentMay 7, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Exercise Pulmonary Hypertension
Sponsor
Aristotle University Of Thessaloniki
Enrollment
40
Locations
1
Primary Endpoint
Change in total pulmonary resistance (TPR) from rest to exercise
Last Updated
7 years ago

Overview

Brief Summary

The study evaluates the rest and exercise hemodynamics of patients presenting either idiopathic fibrotic pulmonary disease or pulmonary fibrosis secondary to connective tissue disease.

Detailed Description

Patients with fibrotic pulmonary disease of the above origin will undergo detailed assessment of functional status with the following examinations: pulmonary function tests, echocardiogram, 6 minute exercise test, cardiopulmonary exercise test (in the absence of contra-indications) and finally right heart catheterization. Hemodynamic assessment will take place at rest and at exercise following the exercise protocol that was recommended by Herve et al (ERJ 2015) using a cycle ergometer at bedside. The purposes of the study are: 1. to evaluate the response of the hemodynamic parameters at exercise compared to the resting parameters in this patient group. 2. to discriminate between precapillary from postcapillary etiology of pulmonary hypertension. 3. to correlate non-invasive parameters of functional limitation with invasive hemodynamic parameters. 4. to assess the prognostic role of exercise induced pulmonary hypertension in the specific patient group.

Registry
clinicaltrials.gov
Start Date
May 7, 2018
End Date
December 15, 2020
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

EVAGGELIA PANAGIOTIDOU

Phd candidate, Resident of Pulmonary medicine, G.H.G.Papanikolaou, Thessaloniki, Greece

Aristotle University Of Thessaloniki

Eligibility Criteria

Inclusion Criteria

  • diagnosis of pulmonary fibrosis secondary to connective tissue disease, according to the American College of Rheumatology/European League Against Rheumatism (ACR-EULAR) revised classification criteria , or diagnosis of idiopathic fibrotic diffuse pulmonary disease according to American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines
  • Forced vital capacity (FVC) ≥ 40 %

Exclusion Criteria

  • Presence of contra-indications to exercise tests, such as acute myocardial infarction, unstable angina, uncontrollable arrythmia or skeletal disease that limits the ability to exercise.
  • History of pulmonary embolism during the year before enrollment
  • Presence of severe valvular disease.
  • Current treatment with vasoactive drugs of the pulmonary circulation
  • Pulmonary wedge pressure (PAWP) at rest \> 15 mmHg

Outcomes

Primary Outcomes

Change in total pulmonary resistance (TPR) from rest to exercise

Time Frame: 2nd minute,4th minute, 6th minute, 8th minute

The patient undergoes right heart catheterization and all hemodynamic variables are measured at rest and at exercise. TPR is derived by the following equation : mean pulmonary artery pressure/ cardiac output (mPAP/CO). TPR is measured at rest and at exercise following a specific protocol. The measurements are made at rest, then at the sequential exercise steps of increasing work resistance.

Study Sites (1)

Loading locations...

Similar Trials